Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Colman

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Journal of Neuro-Oncology|June 8, 2020
Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trialAdam L Cohen, Christopher J Anker, Brett Johnson, et al.
JMIR Human Factors|September 1, 2017
Development of the Electronic Social Network Assessment Program Using the Center for eHealth and Wellbeing Research RoadmapMaija Reblin, Yelena P Wu, Justin Pok, et al.
Oncotarget|February 16, 2011
Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotypeDan Liu, Vanesa Martin, Juan Fueyo, et al.
Neuro-Oncology|February 13, 2010
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaAndreana L Rivera, Christopher E Pelloski, Mark R Gilbert, et al.
The American Journal of Surgical Pathology|May 16, 2006
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomasHoward Colman, Caterina Giannini, Li Huang, et al.
BMC Cancer|March 3, 2019
The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population databaseSarah Hummel, Wendy Kohlmann, Thomas M Kollmeyer, et al.
Acta Neuropathologica Communications|June 21, 2015
DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation statusAdam Cohen, Mariko Sato, Kenneth Aldape, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cellsJeannine Garnett, Vaibhav Chumbalkar, Brian Vaillant, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory GlioblastomaAnna F Piotrowski, Kent Shih, Pierre Giglio, et al.
Journal of Adolescent and Young Adult Oncology|August 5, 2020
Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with CancerAndreana N Holowatyj, Richard Viskochil, Dominik Ose, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Journal of Neuro-Oncology|June 8, 2020
Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trialAdam L Cohen, Christopher J Anker, Brett Johnson, et al.
JMIR Human Factors|September 1, 2017
Development of the Electronic Social Network Assessment Program Using the Center for eHealth and Wellbeing Research RoadmapMaija Reblin, Yelena P Wu, Justin Pok, et al.
Oncotarget|February 16, 2011
Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotypeDan Liu, Vanesa Martin, Juan Fueyo, et al.
Neuro-Oncology|February 13, 2010
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaAndreana L Rivera, Christopher E Pelloski, Mark R Gilbert, et al.
The American Journal of Surgical Pathology|May 16, 2006
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomasHoward Colman, Caterina Giannini, Li Huang, et al.
BMC Cancer|March 3, 2019
The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population databaseSarah Hummel, Wendy Kohlmann, Thomas M Kollmeyer, et al.
Acta Neuropathologica Communications|June 21, 2015
DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation statusAdam Cohen, Mariko Sato, Kenneth Aldape, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cellsJeannine Garnett, Vaibhav Chumbalkar, Brian Vaillant, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory GlioblastomaAnna F Piotrowski, Kent Shih, Pierre Giglio, et al.
Journal of Adolescent and Young Adult Oncology|August 5, 2020
Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with CancerAndreana N Holowatyj, Richard Viskochil, Dominik Ose, et al.
Pageof 16